Ultime notizie per Round One (OTC:RNDOF) Azioni

Round One Corp engages is a Japanese company providing various leisure facilities. The firm principally engages in the management of indoor leisure facilities that mainly includes bowling, amusement activities, spotcher, airporin, spocha, shuttle bus, and karaoke. The company also has operations based in the United States.

Round One Corp

Eledon Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELDN#NASDAQ">ELDN</a>) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.30) by 73.33 percent. This is a 89.87 percent increase over losses of $(0.79) per share from the same period last year.

Earnings

Earnings Beats

News

ELDN

Eledon Pharma Q1 EPS $(0.08) Beats $(0.30) Estimate

Gold miners&#8217; stocks, 2025&#8217;s standout performers, faced a sharp reversal this week as investor appetite for safe havens cooled following the U.S.-China trade truce, raising fresh doubts about the sustainability of<a href="https://www.benzinga.com/topic/gold-miners"> the sector&#8217;s explosive rally.</a>
The VanEck Gold Miners ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDX#NYSE">GDX</a>)—a widely tracked proxy for gold mining stocks—plunged 9.6% over three sessions, marking its worst three-day performance since April 2022. 
The move was amplified by a 4.4% drop in gold prices, which now sit 9.2% below the all-time high of $3,500 per ounce reached on April 22.
Losses were broad-based within the GDX components. Newmont Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>), its largest holding, dropped 10% in just three days. Similar losses were recorded in Barrick Gold Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOLD#NYSE">GOLD</a>) and Agnico Eagle Mines Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEM#NYSE">AEM</a>).
The abrupt reversal comes as risk appetite surges globally, diminishing gold's appeal. The May 12 announcement of a 90-day U.S.-China tariff rollback helped lift equities and risk assets, reducing investor hedges in gold.
<h3 class="wp-block-heading">Technical Setups Signal Caution For Gold</h3>
Technical analysts are growing cautious. Bank of America technical analyst, Paul Ciana said the daily gold chart is showing signs of a potential double top pattern. 
He indicated that a close below $3,200 per ounce would increase the risk of a correction to the $2,900–$3,000 range during the second quarter.
From a fundamental view, David Morrison, senior market analyst at Trade Nation, observed that gold is consolidating around the lower end of its recent range. 
He flagged $3,200 as the first key support level. "It looks as if the path of least resistance may be down for gold, although much now depends on how staunchly the bulls can defend the $3,200 level," he said.
Nikos Tzabouras, senior market analyst at Tradu.com, said the trade truce buoyed market sentiment and reduced near-term demand for havens like gold. 
"Gold remains under pressure, with scope for further declines as risk appetite holds firm," he said, while cautioning that geopolitical uncertainty and central bank buying still support the longer-term case.
<h3 class="wp-block-heading">Seasonality Enters Choppy Phase</h3>
Seasonal trends may also be at play. Historically, gold posts strong gains in the first four months of the year, followed by a choppy stretch between mid-May and mid-July. In that two-month window, bullion has delivered positive returns just 42% of the time over the past decade.
This seasonal lull could compound downside pressure, especially if key support levels fail to hold.
Conclusion: Time to Take Some Chips Off the Table?
While gold miners have delivered strong year-to-date returns – with the GDX ETF up 30% through mid May. 
Yet, the combination of technical weakness, a seasonally soft window, and shifting macro tailwinds suggests a more cautious stance may be warranted in the short term. 
For investors sitting on large gains, this could be an opportune moment to lock in profits—or at least tighten risk controls—while waiting for clearer signals.
Read now: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45410216/cruises-set-sail-ahead-of-summer-boom-these-3-sp-500-stocks-show-strongest-late-may-seasonality">Cruises Set Sail Ahead Of Summer Boom: These 3 S&amp;P 500 Stocks Show Strongest Late-May Seasonality</a><span class="author" style="box-sizing: border-box; border: 0px solid rgb(229, 231, 235); --tw-scale-x: 1; --tw-scale-y: 1; --tw-pan-x: ; --tw-pan-y: ; --tw-pinch-zoom: ; --tw-scroll-snap-strictness: proximity; --tw-gradient-from-position: ; --tw-gradient-via-position: ; --tw-gradient-to-position: ; --tw-ordinal: ; --tw-slashed-zero: ; --tw-numeric-figure: ; --tw-numeric-spacing: ; --tw-numeric-fraction: ; --tw-ring-inset: ; --tw-ring-offset-width: 0px; --tw-ring-offset-color: #fff; --tw-ring-color: rgba(59,130,246,.5); --tw-ring-offset-shadow: 0 0 #0000; --tw-ring-shadow: 0 0 #0000; --tw-shadow: 0 0 #0000; --tw-shadow-colored: 0 0 #0000; --tw-blur: ; --tw-brightness: ; --tw-contrast: ; --tw-grayscale: ; --tw-hue-rotate: ; --tw-invert: ; --tw-saturate: ; --tw-sepia: ; --tw-drop-shadow: ; --tw-backdrop-blur: ; --tw-backdrop-brightness: ; --tw-backdrop-contrast: ; --tw-backdrop-grayscale: ; --tw-backdrop-hue-rotate: ; --tw-backdrop-invert: ; --tw-backdrop-opacity: ; --tw-backdrop-saturate: ; --tw-backdrop-sepia: ; --tw-contain-size: ; --tw-contain-layout: ; --tw-contain-paint: ; --tw-contain-style: ;"></li>
</ul>
Photo: Shutterstock

Analyst Color

Equities

Large Cap

Macro Economic Events

Sector ETFs

Econ #s

Economics

Analyst Ratings

Tech

ETFs

Market Vectors ETF Trust Market Vectors Gold Miners

GOLD

Gold Miners Slammed By US-China Trade Truce: Is It Time To Take Profit?

BioCardia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCDA#NASDAQ">BCDA</a>) reported quarterly losses of $(0.59) per share which missed the analyst consensus estimate of $(0.39) by 51.28 percent. This is a 56.3 percent increase over losses of $(1.35) per share from the same period last year.

Earnings Misses

BCDA

BioCardia Q1 EPS $(0.59) Misses $(0.39) Estimate

Conifer Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNFR#NASDAQ">CNFR</a>) reported quarterly losses of $(0.30) per share. This is a 372.73 percent decrease over earnings of $0.11 per share from the same period last year. The company reported $10.31 million in sales this quarter. This is a 38.92 percent decrease over sales of $16.89 million the same period last year.

CNFR

Conifer Holdings Q1 Adj. EPS $(0.30) Down From $0.11 YoY, Sales $10.31M Down From $16.89M YoY

WIIM

BOOT

Boot Barn Holdings shares are trading higher after the company issued Q1 guidance with its midpoint above estimates and announced a $200 million share repurchase program.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

Canaan For April Mined 87 Bitcoins

Zentalis Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZNTL#NASDAQ">ZNTL</a>) reported quarterly losses of $(0.67) per share which missed the analyst consensus estimate of $(0.63) by 6.35 percent. This is a 578.57 percent decrease over earnings of $0.14 per share from the same period last year.

ZNTL

Zentalis Pharma Q1 EPS $(0.67) Misses $(0.63) Estimate

DXC Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DXC#NYSE">DXC</a>) reported quarterly earnings of $0.84 per share which beat the analyst consensus estimate of $0.77 by 9.09 percent. This is a 13.4 percent decrease over earnings of $0.97 per share from the same period last year. The company reported quarterly sales of $3.17 billion which beat the analyst consensus estimate of $3.13 billion by 1.16 percent. This is a 6.41 percent decrease over sales of $3.39 billion the same period last year.

DXC Technology Q4 Adj. EPS $0.84 Beats $0.77 Estimate, Sales $3.17B Beat $3.13B Estimate

CRWV

CoreWeave Q1 Adj. EPS $(0.599) May Not Compare To $(0.12) Estimate

Electrovaya (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELVA#NASDAQ">ELVA</a>) FY2025 Revenue expected to be more than $60.00M vs $67.92M Est

Guidance

ELVA

Electrovaya FY2025  Revenue expected to be more than $60.00M vs $67.92M Est

GCT Semiconductor Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GCTS#NYSE">GCTS</a>) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.10) by 50 percent. This is a 600 percent decrease over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of $496.00 thousand which missed the analyst consensus estimate of $1.87 million by 73.53 percent. This is a 84.81 percent decrease over sales of $3.27 million the same period last year.

GCTS

GCT Semiconductor Hldgs Q1 EPS $(0.15) Misses $(0.10) Estimate, Sales $496.00K Miss $1.87M Estimate

Boot Barn Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOOT#NYSE">BOOT</a>) is looking for Q1 GAAP EPS of $1.44-$1.52 vs $1.44 analyst estimate. sees sales of $483.000 million-$491.000 million vs $486.49 million analyst estimate.

Boot Barn Holdings Sees Q1 GAAP EPS $1.44-$1.52 vs $1.44 Est; Sees Sales $483.000M-$491.000M vs $486.49M Est

Boot Barn Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOOT#NYSE">BOOT</a>) is looking for FY2026 GAAP EPS of $5.50-$6.40 vs $6.24 analyst estimate. sees sales of $2.070 billion-$2.150 billion vs $2.17 billion analyst estimate.

Boot Barn Holdings Sees FY2026 GAAP EPS $5.50-$6.40 vs $6.24 Est; Sees Sales $2.070B-$2.150B vs $2.17B Est

Electrovaya (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELVA#NASDAQ">ELVA</a>) reported quarterly earnings of $0.02 per share which missed the analyst consensus estimate of $0.03 by 33.33 percent. This is a 200 percent increase over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $15.02 million which missed the analyst consensus estimate of $15.95 million by 5.84 percent. This is a 40.42 percent increase over sales of $10.70 million the same period last year.

Electrovaya Q2 EPS $0.02 Misses $0.03 Estimate, Sales $15.02M Miss $15.95M Estimate

Biotech

General

SILO

Silo Pharma Engages Veloxity Labs For Bioanalytical IND-Enabling Study For Novel Intranasal PTSD Therapy, SPC-15

The Beachbody Company, Inc. Class A Common Stock

BODI

The Beachbody Company shares are trading higher after the company reported better-than-expected Q1 financial results and issued Q2 sales guidance with its midpoint above estimates.

Maze Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAZE#NASDAQ">MAZE</a>) reported quarterly losses of $(1.15) per share. This is a 91.73 percent increase over losses of $(13.91) per share from the same period last year.

MAZE

Maze Therapeutics Q1 EPS $(1.15) Up From $(13.91) YoY

Acuren Uplists To NYSE

Pony AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PONY#NASDAQ">PONY</a>) stock traded lower on Wednesday. <a href="https://www.cnbc.com/2025/05/14/chinese-robotaxi-operator-ponyai-reports-first-fire-no-injuries.html">CNBC </a>reported that one of the company&#8217;s robotaxis <a href="https://www.benzinga.com/25/05/45416148/pony-ai-shares-rise-after-report-of-confidential-hong-kong-ipo-to-fund-robotaxi-expansion">caught on fire.</a>
The Details: The incident occurred in Beijing, with no passengers involved. This marks the first time one of Pony AI&#8217;s robotaxis has caught fire.
Pony AI said one of its fully autonomous vehicles was found to have an abnormal status in Beijing around 9:30 a.m. local time on May 13. Service workers arrived within two minutes, but the vehicle caught fire during the response.
The company has not announced the cause of the fire.
PONY Price Action: PONY AI shares are down 5.68% at $16.93 on Wednesday, according to data from <a href="https://www.benzinga.com/pro/login">Benzinga Pro.</a>
See Also: • <a href="https://www.benzinga.com/25/05/45417156/nvidia-amd-stocks-climb-as-trump-plans-to-ease-ai-chip-export-rules">Nvidia, AMD And Other Chip Stocks Gain As Trump Plans To Ease AI Chip Export Rules</a>
Photo: via Shutterstock

Movers

PONY

Pony AI Stock Is Sliding Wednesday: What's Going On?

Challenge Study measured safety, efficacy against infection and symptomatic disease as well as viral shedding
Machine learning analyses identified statistically significant correlates of protection and will be incorporated into the development of Vaxart's second-generation norovirus vaccine candidate, which is being evaluated in a Phase 1 clinical trial

VXRT

Vaxart Publishes Complete Data From Phase 2b Challenge Study Of First-Generation Oral Pill Norovirus Vaccine Candidate In Science Translational Medicine

Comments

Round One

Notizie

Ultime notizie per Round One (OTC:RNDOF) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO